Impairment of macrophage function by inhibitors of ornithine decarboxylase activity.
The effects of irreversible inhibition of ornithine decarboxylase on the capacity of murine macrophages to take up a protozoan organism (Trypanosoma cruzi) or inert particles were investigated. Incubation of macrophage cultures with four different ornithine decarboxylase inhibitors, namely, DL-alpha-difluoromethylornithine (DFMO, 0.5 to 20 mM), delta-methyl-acetylenic putrescine (1 to 5 mM), monofluoromethyldehydroornithine ethyl ester (1 to 5 mM), and monofluoromethyldehydroornithine methyl ester (1 to 5 mM), before the addition of the parasites significantly reduced the percentage of macrophages with parasites, indicating that some of the host cells were no longer capable of binding or ingesting the parasite. The average number of trypanosomes per 100 macrophages was also diminished, denoting a lesser phagocytic capacity as a consequence of the treatments. These effects were reversible within 2 h after removal of excess DFMO. No alteration in parasite-macrophage interaction was seen when the trypanosomes were treated with DFMO. That the effects of DFMO on the macrophages probably resulted from a reduction in polyamine levels caused by inhibition of ornithine decarboxylase was indicated by the fact that these effects were not seen when the macrophages were incubated with DFMO in the presence of putrescine, the product of ornithine decarboxylation by ornithine decarboxylase. DFMO treatment of macrophages also inhibited the capacity of these cells to ingest killed parasites or latex beads and thus appeared to generally affect phagocytosis. An effect of DFMO on the susceptibility of macrophages to penetration by the parasites seemed less likely because no significant alteration in cell-parasite association occurred when myoblasts--which, not being phagocytic, can be infected only by membrane penetration--were treated with DFMO. Taken together, these results emphasize a role of ornithine decarboxylase activity and polyamine biosynthesis in macrophage function.
D000818:Animals; D002478:Cells, Cultured; D000518:Eflornithine / Q000031:analogs & derivatives / Q000494:pharmacology; D008264:Macrophages / Q000201:enzymology / Q000276:immunology* / Q000469:parasitology; D051379:Mice; D008808:Mice, Inbred CBA; D008863:Microspheres; D009206:Myocardium / Q000166:cytology; D009955:Ornithine Decarboxylase / Q000378:metabolism; D065108:Ornithine Decarboxylase Inhibitors; D010587:Phagocytosis; D011700:Putrescine / Q000378:metabolism; D014349:Trypanosoma cruzi / Q000276:immunology / Q000378:metabolism*
D065108:Ornithine Decarboxylase Inhibitors; C047399:2-(fluoromethyl)dehydroornithine methyl ester; D009955:Ornithine Decarboxylase; D011700:Putrescine; D000518:Eflornithine